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Several international treatment guidelines now recom-
mend that antiretroviral therapy should be initiated in all
patients with a CD4 count below 350 cells/mm3. How-
ever, about 57% of UK patients are currently diagnosed
with CD4 counts under 350, and 20% of patients cur-
rently with CD4 counts under this figure and diagnosed
for longer than three months are not taking ARVs [1]. This
plenary presentation will review the evidence for when to
start therapy, look at CD4 counts at the start of therapy
from European cohort studies, and analyse studies of
patient opinion on ARV therapy and when to initiate it. It
will also present information from an online survey of
patients' knowledge and opinions on when to start ther-
apy from the global HIV information website http://
www.aidsmap.com.
References
1. Chadborn T, Delpech V: What are the implications of increas-
ing the recommended threshold for starting anti-HIV ther-
apy (ART)?  Fourteenth BHIVA Conference, Belfast 2008:Abstract O20.
from Ninth International Congress on Drug Therapy in HIV Infection
Glasgow, UK. 9–13 November 2008
Published: 10 November 2008
Journal of the International AIDS Society 2008, 11(Suppl 1):O43 doi:10.1186/1758-2652-11-S1-O43
<supplement> <title> <p>Abstracts of the Ninth International Congress on Drug Therapy in HIV Infection</p> </title> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1758-2652-11-S1-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1758-2652-11-S1-info.pdf</url> </supplement>
This abstract is available from: http://www.jiasociety.org/content/11/S1/O43
© 2008 Cairns and Alcorn; licensee BioMed Central Ltd. 
